|
DWTX Dogwood Therapeutics Inc 1818844 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-4,986,614.00 |
| Balance Sheet |
|
Current Assets
|
$15,004,138.00 |
|
Assets
|
$95,207,871.00 |
|
Current Liabilities
|
$2,560,024.00 |
|
Liabilities
|
$14,584,519.00 |
|
Equity
|
$80,623,352.00 |
|
Shares Out
|
33401553.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-4,587,187.00 |
|
Investing Cash Flow
|
$3,761,936.00 |
| Market Analysis |
Market Cap
|
$52,774,453.74 |
|
Price
|
$1.64 |
|
BVPS
|
2.41 |
|
PB
|
0.66 |
|
EPS
|
-0.15 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:40 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:39 |
|
| Apr |
May |
Jun |
| 2026-03-18 |
-0.26 |
|
|
|
|
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-13 |
-1.99 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-06 |
-8.20 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view DWTX documents filed with the SEC.
DWTX Filings
Clear
